These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29432858)

  • 1. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
    Schünemann HJ; Cuello C; Akl EA; Mustafa RA; Meerpohl JJ; Thayer K; Morgan RL; Gartlehner G; Kunz R; Katikireddi SV; Sterne J; Higgins JP; Guyatt G;
    J Clin Epidemiol; 2019 Jul; 111():105-114. PubMed ID: 29432858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence].
    Morche J; Freitag S; Hoffmann F; Rissling O; Langer G; Nußbaumer-Streit B; Toews I; Gartlehner G; Meerpohl JJ
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():124-133. PubMed ID: 31980320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the trustworthiness of findings from nutrition evidence syntheses: assessing risk of bias and rating the certainty of evidence.
    Schwingshackl L; Schünemann HJ; Meerpohl JJ
    Eur J Nutr; 2021 Sep; 60(6):2893-2903. PubMed ID: 33377996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting GRADE's levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?
    Schünemann HJ
    J Clin Epidemiol; 2016 Jul; 75():6-15. PubMed ID: 27063205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness.
    Zhang Y; Alonso-Coello P; Guyatt GH; Yepes-Nuñez JJ; Akl EA; Hazlewood G; Pardo-Hernandez H; Etxeandia-Ikobaltzeta I; Qaseem A; Williams JW; Tugwell P; Flottorp S; Chang Y; Zhang Y; Mustafa RA; Rojas MX; Schünemann HJ
    J Clin Epidemiol; 2019 Jul; 111():94-104. PubMed ID: 29452223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading of Recommendations Assessment, Development, and Evaluations (GRADE) notes: extremely serious, GRADE's terminology for rating down by three levels.
    Piggott T; Morgan RL; Cuello-Garcia CA; Santesso N; Mustafa RA; Meerpohl JJ; Schünemann HJ;
    J Clin Epidemiol; 2020 Apr; 120():116-120. PubMed ID: 31866468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to interpret the certainty of evidence based on GRADE (Grading of Recommendations, Assessment, Development and Evaluation)].
    Schwingshackl L; Rüschemeyer G; Meerpohl JJ
    Urologe A; 2021 Apr; 60(4):444-454. PubMed ID: 33620513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines.
    Cuello-Garcia CA; Santesso N; Morgan RL; Verbeek J; Thayer K; Ansari MT; Meerpohl J; Schwingshackl L; Katikireddi SV; Brozek JL; Reeves B; Murad MH; Falavigna M; Mustafa R; Regidor DL; Alexander PE; Garner P; Akl EA; Guyatt G; Schünemann HJ
    J Clin Epidemiol; 2022 Feb; 142():200-208. PubMed ID: 34800676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.
    Brozek JL; Canelo-Aybar C; Akl EA; Bowen JM; Bucher J; Chiu WA; Cronin M; Djulbegovic B; Falavigna M; Guyatt GH; Gordon AA; Hilton Boon M; Hutubessy RCW; Joore MA; Katikireddi V; LaKind J; Langendam M; Manja V; Magnuson K; Mathioudakis AG; Meerpohl J; Mertz D; Mezencev R; Morgan R; Morgano GP; Mustafa R; O'Flaherty M; Patlewicz G; Riva JJ; Posso M; Rooney A; Schlosser PM; Schwartz L; Shemilt I; Tarride JE; Thayer KA; Tsaioun K; Vale L; Wambaugh J; Wignall J; Williams A; Xie F; Zhang Y; Schünemann HJ;
    J Clin Epidemiol; 2021 Jan; 129():138-150. PubMed ID: 32980429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.
    Dickman MM; Spekreijse LS; Winkens B; Schouten JS; Simons RW; Dirksen CD; Nuijts RM
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013270. PubMed ID: 35467755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Guyatt G; Akl EA; Oxman A; Wilson K; Puhan MA; Wilt T; Gutterman D; Woodhead M; Antman EM; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):256-61. PubMed ID: 23256168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.
    Bero L; Chartres N; Diong J; Fabbri A; Ghersi D; Lam J; Lau A; McDonald S; Mintzes B; Sutton P; Turton JL; Woodruff TJ
    Syst Rev; 2018 Dec; 7(1):242. PubMed ID: 30577874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review.
    Igelström E; Campbell M; Craig P; Katikireddi SV
    J Clin Epidemiol; 2021 Dec; 140():22-32. PubMed ID: 34437948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains.
    Zhang Y; Coello PA; Guyatt GH; Yepes-Nuñez JJ; Akl EA; Hazlewood G; Pardo-Hernandez H; Etxeandia-Ikobaltzeta I; Qaseem A; Williams JW; Tugwell P; Flottorp S; Chang Y; Zhang Y; Mustafa RA; Rojas MX; Xie F; Schünemann HJ
    J Clin Epidemiol; 2019 Jul; 111():83-93. PubMed ID: 29800687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks.
    Foroutan F; Guyatt G; Zuk V; Vandvik PO; Alba AC; Mustafa R; Vernooij R; Arevalo-Rodriguez I; Munn Z; Roshanov P; Riley R; Schandelmaier S; Kuijpers T; Siemieniuk R; Canelo-Aybar C; Schunemann H; Iorio A
    J Clin Epidemiol; 2020 May; 121():62-70. PubMed ID: 31982539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.
    Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L
    Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.